NO973873D0 - Hepatitt B vaksine - Google Patents

Hepatitt B vaksine

Info

Publication number: NO973873D0
Authority: NO; Norway
Prior art keywords: vaccine; hepatitis
Prior art date: 1995-02-25

Application number

NO973873A

Other languages

English (en)

Other versions

NO973873L (no

NO319394B1 (no

Inventor

Pierre Hauser

Nathalie Marie-Josephe Garcon

Pierre Desmons

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-25

Filing date

1997-08-22

Publication date

1997-08-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770292&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO973873(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-08-22 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

1997-08-22 Publication of NO973873L publication Critical patent/NO973873L/no

1997-08-22 Publication of NO973873D0 publication Critical patent/NO973873D0/no

2005-08-08 Publication of NO319394B1 publication Critical patent/NO319394B1/no

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO19973873A 1995-02-25 1997-08-22 Hepatitt B vaksine NO319394B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9503863.4A GB9503863D0 (en)	1995-02-25	1995-02-25	Vaccine compositions
PCT/EP1996/000681 WO1996026741A1 (en)	1995-02-25	1996-02-15	Hepatitis b vaccine

Publications (3)

Publication Number	Publication Date
NO973873L NO973873L (no)	1997-08-22
NO973873D0 true NO973873D0 (no)	1997-08-22
NO319394B1 NO319394B1 (no)	2005-08-08

Family

ID=10770292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19973873A NO319394B1 (no)	1995-02-25	1997-08-22	Hepatitt B vaksine

Country Status (36)

Country	Link
US (1)	US5972346A (no)
EP (1)	EP0810877B1 (no)
JP (1)	JP3881015B2 (no)
KR (1)	KR100365373B1 (no)
CN (1)	CN1101225C (no)
AP (1)	AP766A (no)
AR (1)	AR002279A1 (no)
AT (1)	ATE209045T1 (no)
AU (1)	AU695921B2 (no)
BG (1)	BG101851A (no)
BR (1)	BR9607458A (no)
CA (1)	CA2212552C (no)
CZ (1)	CZ288417B6 (no)
DE (1)	DE69617211T2 (no)
DK (1)	DK0810877T3 (no)
EA (1)	EA199700126A1 (no)
ES (1)	ES2166879T3 (no)
FI (1)	FI118118B (no)
GB (1)	GB9503863D0 (no)
HK (1)	HK1004117A1 (no)
HU (1)	HU224832B1 (no)
IL (1)	IL117249A (no)
MA (1)	MA23814A1 (no)
MX (1)	MX9706450A (no)
MY (1)	MY113428A (no)
NO (1)	NO319394B1 (no)
NZ (1)	NZ302674A (no)
OA (1)	OA10612A (no)
PL (1)	PL182679B1 (no)
PT (1)	PT810877E (no)
SA (1)	SA96160633B1 (no)
SK (1)	SK115097A3 (no)
TR (1)	TR199700849T1 (no)
TW (1)	TW467745B (no)
WO (1)	WO1996026741A1 (no)
ZA (1)	ZA961460B (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6620414B2 (en) *	1992-03-27	2003-09-16	Smithkline Beecham Biologicals (S.A.)	Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
US6488934B1 (en) *	1995-02-25	2002-12-03	Smithkline Beecham Biologicals S.A.	Hepatitis B vaccine
US20010014331A1 (en) *	1996-11-07	2001-08-16	Smithkline Beecham Biologicals S.A.	Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
GB9809507D0 (en) *	1998-05-01	1998-07-01	Smithkline Beecham Biolog	Novel composition
US20030049268A1 (en)	1998-05-01	2003-03-13	Smithkline Beecham Biologicals S.A.	Novel composition
DE69932717T2 (de)	1998-05-22	2007-08-09	Ottawa Health Research Institute, Ottawa	Methoden und produkte zur induzierung mukosaler immunität
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
DE69935606T9 (de)	1998-10-16	2021-03-11	Glaxosmithkline Biologicals S.A.	Adjuvanzsysteme und impfstoffe
CU22871A1 (es) *	1998-12-02	2003-10-21	Ct Ingenieria Genetica Biotech	Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
EP1140155A4 (en) *	1998-12-23	2004-11-03	Merck & Co Inc	IMPROVED RECOMBINATION HEPATITIS B ENVELOPE ANTIGEN
WO2000062800A2 (en)	1999-04-19	2000-10-26	Smithkline Beecham Biologicals Sa	Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
CU23031A1 (es) *	2002-01-24	2005-02-23	Ct Ingenieria Genetica Biotech	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
MX2007009961A (es) *	2005-02-16	2008-01-29	Novartis Vaccines & Diagnostic	Composicion adyuvante que comprende fosfato de aluminio y 3d-mpl.
EA014314B1 (ru) *	2005-08-02	2010-10-29	Новартис Вэксинес Энд Дайэгностикс Срл	Пониженная интерференция между маслосодержащими адъювантами и антигенами, содержащими поверхностно-активные вещества
WO2007052155A2 (en)	2005-11-04	2007-05-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
CA2628152C (en)	2005-11-04	2016-02-02	Novartis Vaccines And Diagnostics S.R.L.	Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
NZ568211A (en)	2005-11-04	2011-11-25	Novartis Vaccines & Diagnostic	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
US20110180430A1 (en)	2005-11-04	2011-07-28	Novartis Vaccines And Diagnostics Srl	Adjuvanted influenza vaccines including cytokine-inducing agents
CN100415294C (zh) *	2005-12-23	2008-09-03	中国农业大学	一种治疗和/或预防乙肝的药物
DK1976559T6 (da)	2006-01-27	2020-04-06	Seqirus Uk Ltd	Influenzavacciner indeholdende hæmagglutinin og matrixproteiner
ES2536426T3 (es)	2006-03-23	2015-05-25	Novartis Ag	Compuestos de imidazoquinoxalina como inmunomoduladores
EP2004226A1 (en)	2006-03-24	2008-12-24	Novartis Vaccines and Diagnostics GmbH & Co. KG	Storage of influenza vaccines without refrigeration
EP1862176A1 (de) *	2006-05-31	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) *	2006-06-01	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
US20110206692A1 (en)	2006-06-09	2011-08-25	Novartis Ag	Conformers of bacterial adhesins
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
CA2663196A1 (en)	2006-09-11	2008-03-20	Novartis Ag	Making influenza virus vaccines without using eggs
NZ577405A (en)	2006-12-06	2012-08-31	Novartis Ag	Vaccines including antigen from four strains of influenza virus
EA201070066A1 (ru)	2007-06-27	2010-06-30	Новартис Аг	Вакцины против гриппа с низким содержанием добавок
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
CA2710480A1 (en)	2007-12-24	2009-07-02	Novartis Ag	Assays for adsorbed influenza vaccines
DK3178490T3 (da)	2009-07-15	2022-06-20	Glaxosmithkline Biologicals Sa	RSV F-proteinsammensætninger og fremgangsmåder til fremstilling af disse
EP3527224A1 (en)	2011-01-26	2019-08-21	GlaxoSmithKline Biologicals S.A.	Rsv immunization regimen
US9452212B2 (en)	2011-04-14	2016-09-27	Dynavax Technologies Corporation	Methods and compositions for eliciting an immune response against hepatitis B virus
PT2707385T (pt)	2011-05-13	2017-12-19	Glaxosmithkline Biologicals Sa	Antigénios de f de rsv pré-fusão
US11013795B2 (en)	2015-06-26	2021-05-25	Seqirus UK Limited	Antigenically matched influenza vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
EP0414374B1 (en) *	1989-07-25	1997-10-08	Smithkline Biologicals S.A.	Novel antigens and methods for their preparation
EP0835639A3 (en) *	1991-05-29	1999-04-07	Origin Medsystems, Inc.	Retraction apparatus for endoscopic surgery
MA22842A1 (fr) *	1992-03-27	1993-10-01	Smithkline Beecham Biolog	Procede de preparation de compositions de vaccin.
EP0835663B1 (en) *	1992-05-23	2009-09-30	GlaxoSmithKline Biologicals S.A.	Combined vaccines comprising Hepatitis B surface antigen and other antigens
HU219056B (hu) *	1993-03-23	2001-02-28	Smithkline Beecham Biologicals Sa	3-O-Dezacilezett monofoszforil-lipid A-t tartalmazó vakcinakészítmény
GB9311536D0 (en) *	1993-06-04	1993-07-21	Unilever Plc	Hot soluble low density extractable food product

1995
- 1995-02-25 GB GBGB9503863.4A patent/GB9503863D0/en active Pending
1996
- 1996-02-14 MY MYPI96000567A patent/MY113428A/en unknown
- 1996-02-15 AU AU48780/96A patent/AU695921B2/en not_active Ceased
- 1996-02-15 ES ES96904814T patent/ES2166879T3/es not_active Expired - Lifetime
- 1996-02-15 AP APAP/P/1997/001060A patent/AP766A/en active
- 1996-02-15 EA EA199700126A patent/EA199700126A1/ru unknown
- 1996-02-15 SK SK1150-97A patent/SK115097A3/sk unknown
- 1996-02-15 WO PCT/EP1996/000681 patent/WO1996026741A1/en active IP Right Grant
- 1996-02-15 PL PL96321966A patent/PL182679B1/pl unknown
- 1996-02-15 BR BR9607458A patent/BR9607458A/pt not_active IP Right Cessation
- 1996-02-15 EP EP96904814A patent/EP0810877B1/en not_active Expired - Lifetime
- 1996-02-15 DK DK96904814T patent/DK0810877T3/da active
- 1996-02-15 PT PT96904814T patent/PT810877E/pt unknown
- 1996-02-15 NZ NZ302674A patent/NZ302674A/xx not_active IP Right Cessation
- 1996-02-15 DE DE69617211T patent/DE69617211T2/de not_active Expired - Lifetime
- 1996-02-15 AT AT96904814T patent/ATE209045T1/de active
- 1996-02-15 KR KR1019970705880A patent/KR100365373B1/ko not_active IP Right Cessation
- 1996-02-15 CZ CZ19972674A patent/CZ288417B6/cs not_active IP Right Cessation
- 1996-02-15 CA CA002212552A patent/CA2212552C/en not_active Expired - Fee Related
- 1996-02-15 HU HU9801242A patent/HU224832B1/hu not_active IP Right Cessation
- 1996-02-15 JP JP52598896A patent/JP3881015B2/ja not_active Expired - Fee Related
- 1996-02-15 TR TR97/00849T patent/TR199700849T1/xx unknown
- 1996-02-15 CN CN96192146A patent/CN1101225C/zh not_active Expired - Fee Related
- 1996-02-15 US US08/894,643 patent/US5972346A/en not_active Expired - Lifetime
- 1996-02-22 AR ARP960101469A patent/AR002279A1/es active IP Right Grant
- 1996-02-23 IL IL11724996A patent/IL117249A/xx not_active IP Right Cessation
- 1996-02-23 ZA ZA961460A patent/ZA961460B/xx unknown
- 1996-02-23 MA MA24171A patent/MA23814A1/fr unknown
- 1996-02-26 TW TW085102154A patent/TW467745B/zh not_active IP Right Cessation
- 1996-03-02 SA SA96160633A patent/SA96160633B1/ar unknown
1997
- 1997-08-02 OA OA70066A patent/OA10612A/en unknown
- 1997-08-22 NO NO19973873A patent/NO319394B1/no not_active IP Right Cessation
- 1997-08-22 MX MX9706450A patent/MX9706450A/es unknown
- 1997-08-22 FI FI973457A patent/FI118118B/fi not_active IP Right Cessation
- 1997-08-25 BG BG101851A patent/BG101851A/xx unknown
1998
- 1998-04-28 HK HK98103600A patent/HK1004117A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL182679B1 (pl)	2002-02-28
BG101851A (en)	1998-04-30
CZ267497A3 (cs)	1998-02-18
HUP9801242A3 (en)	2000-08-28
WO1996026741A1 (en)	1996-09-06
AR002279A1 (es)	1998-03-11
MX9706450A (es)	1998-07-31
NO973873L (no)	1997-08-22
AU4878096A (en)	1996-09-18
IL117249A0 (en)	1996-06-18
CN1101225C (zh)	2003-02-12
HU224832B1 (en)	2006-03-28
PL321966A1 (en)	1998-01-05
EP0810877B1 (en)	2001-11-21
DE69617211D1 (en)	2002-01-03
NZ302674A (en)	1999-01-28
AU695921B2 (en)	1998-08-27
NO319394B1 (no)	2005-08-08
SA96160633B1 (ar)	2005-10-15
KR19980702480A (ko)	1998-07-15
HK1004117A1 (en)	1998-11-20
OA10612A (en)	2002-08-29
FI973457A0 (fi)	1997-08-22
BR9607458A (pt)	1998-06-30
GB9503863D0 (en)	1995-04-19
MA23814A1 (fr)	1996-10-01
CN1176604A (zh)	1998-03-18
TW467745B (en)	2001-12-11
JPH11501018A (ja)	1999-01-26
FI973457A (fi)	1997-08-22
EP0810877A1 (en)	1997-12-10
ATE209045T1 (de)	2001-12-15
JP3881015B2 (ja)	2007-02-14
DK0810877T3 (da)	2002-02-25
TR199700849T1 (xx)	1998-01-21
CZ288417B6 (en)	2001-06-13
SK115097A3 (en)	1998-02-04
ES2166879T3 (es)	2002-05-01
AP9701060A0 (en)	1997-10-31
FI118118B (fi)	2007-07-13
AP766A (en)	1999-09-17
HUP9801242A1 (hu)	1998-08-28
DE69617211T2 (de)	2002-07-25
EA199700126A1 (ru)	1998-02-26
CA2212552A1 (en)	1996-09-06
IL117249A (en)	2000-11-21
PT810877E (pt)	2002-04-29
KR100365373B1 (ko)	2003-07-07
ZA961460B (en)	1996-08-29
US5972346A (en)	1999-10-26
CA2212552C (en)	2006-07-11
MY113428A (en)	2002-02-28

Legal Events

Date	Code	Title	Description
2016-02-22	MK1K	Patent expired

Publication	Publication Date	Title
DE69617211T2 (de)	2002-07-25	Hepatitis b impfstoff
NO976060D0 (no)	1997-12-23	Vaksiner mot hepatitt C
NO20003303L (no)	2000-08-04	Vaksine
BR9711853A (pt)	1999-08-24	Vacinas
KR970704468A (ko)	1997-09-06	폴리에피토프 백신(polyepitope vaccines)
ID20399A (id)	1998-12-10	Vaksin influensa
DE69126606D1 (de)	1997-07-24	Vakzine
DK0736303T3 (da)	2000-01-10	Interferonopløsning
DE69510024D1 (de)	1999-07-08	Spritze
DK0863991T3 (da)	2004-02-09	Antigeniske præparater
DE69509766D1 (de)	1999-06-24	Mikroemulsionen
DE69628167D1 (de)	2003-06-18	Spezifische oligonukleotide fuer hepatitis c-virus
IT1276662B1 (it)	1997-11-03	Vaccini polinucleotidici
NO933600D0 (no)	1993-10-08	Termostabile virus
ITMI950511A0 (it)	1995-03-16	Fotodensitometro parallelo perfezionato
SI0810877T1 (en)	2002-06-30	Hepatitis b vaccine
DE69326536T2 (de)	2000-03-02	Antitumor Impfstoff
FI944558A0 (fi)	1994-09-30	Virus
UA24703A (uk)	1998-10-30	Емітерний повторювач
NO980721D0 (no)	1998-02-20	Vaksiner
KR970703417A (ko)	1997-07-03	유두종 바이러스 백신(Papillomavirus vaccines)
SE9501165D0 (sv)	1995-03-31	Hållaranordning
BR7500363U (pt)	1995-06-13	Formulário
KR970000373U (ko)	1997-01-21	세척기
KR960036267U (ko)	1996-12-16	세척기